Asia tech stocks slide tracking Wall St losses amid AI doubts, govt. uncertainty
ARLINGTON, Va. - Privia Health Group , Inc. (NASDAQ:PRVA) saw its shares jump 7.2% after the healthcare technology company reported fourth-quarter earnings and revenue that handily beat analyst expectations.
The company posted adjusted earnings per share of $0.21 for Q4, significantly surpassing the analyst consensus estimate of $0.05. Revenue came in at $460.9 million, also topping expectations of $420.94 million.
Privia Health’s strong performance was driven by robust growth in implemented providers, which increased 11.2% YoY to 4,789 by the end of 2024. The company also saw attributed lives rise 12.1% to 1.26 million.
"We delivered very strong results across all key metrics in 2024, exceeding the high end of our guidance ranges," said Shawn Morris, CEO of Privia Health. "Our continued momentum in new provider signings and solid execution in both fee-for-service and value-based care arrangements drove our financial outperformance."
For the full year 2024, Privia Health reported revenue of $1.74 billion, up 4.7% YoY. Adjusted EBITDA grew 25.2% to $90.5 million.
Looking ahead, the company provided 2025 revenue guidance of $1.8-1.9 billion, compared to the analyst consensus of $1.89 billion. Privia Health expects implemented providers to grow 8.6-10.7% in 2025.
The company ended 2024 with $491.1 million in cash and no debt, putting it in a strong financial position to pursue growth initiatives. Privia Health’s focus areas for 2025 include increasing provider density in existing markets and expanding into new states.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.